Serum concentrations (log2) of M65 were higher among patients with severe COVID-19 (Fig. 2D) and positively correlated with serum IL-1β concentrations (Spearman’s r = 0.34, p = 0.0024) (Fig. 2E). This evidence concerns the gene IL1B and COVID-19.